| |
NewswireTODAY - /newswire/ -
Daejeon, Chungchungnamdo, Korea (South), 2012/12/20 - Panagene and Biosynthesis, Inc. (Lewisville, Texas) have agreed to settle Panagene’s allegations of patent infringement that were pending in the United States District Court for the Eastern District of Texas - Panagene.com.
|
| |
Panagene, Inc. announced today that Panagene and Biosynthesis, Inc. (Lewisville, Texas) have agreed to settle Panagene’s allegations of patent infringement that were pending in the United States District Court for the Eastern District of Texas. The terms of the settlement include Biosynthesis’ undisclosed payments of past damages and stopping immediately all PNA products sales and PNA-related services. Panagene alleged that Biosynthesis’ PNA products and PNA-related services infringe two patents exclusively licensed by Panagene: United States Patent Nos. 6,395, 474 and 7,378, 485. These patents cover multiple aspects of PNA (Peptide nucleic acids, artificial DNA) material and technology, including PNA oligomers, PNA monomers, and PNA uses in diagnostics.
“Intellectual properties are keys of advancing technology and Panagene is investing significant resources to develop and license in new technologies to support the needs of the advanced PNA diagnostic for personalized medicine and therapeutic market. We have, and will continue to enforce our patent rights,” said Dr. Sungkee Kim, President and CEO of Panagene, Inc. “Panagene is pleased to have achieved a favorable resolution of the patent infringement action against Biosynthesis.”
About Panagene
Panagene, Inc. (panagene.com), a listed company headquartered in Daejeon, Korea, is exclusively licensed PNA supplier worldwide. Panagene developed and patented efficient PNA production processes for PNA oligomers in high purity and large quantities. Panagene have also developed PNA-based diagnostic technology such as PNAClamp™ and PANArray™ (PNA microarray chip) and delivers highly sensitive and specific diagnostic products for detections of gene mutations and genotypes of pathogens.
Panagene has distributors in the U.S., Austria, Belgium, Bulgaria, China, Czech Republic, India, Iran, Israel, Japan, Spain, Taiwan, and UK.
|
info[.]panagene.com 
